Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin-bound Paclitaxel + Oxaliplatin in Advanced Hepatobiliary and Malignant Tumors
NCT04060472Phase 3Unknown
- Start
- Aug 2019
- Primary completion
- Apr 2021
- Modality
- Polymer-based Nanoparticles, Small Molecules
01
Overview
A Phase 3 trial of nab-paclitaxel in hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), extrahepatic cholangiocarcinoma (eCCA), gallbladder carcinoma, pancreatic cancer (PC). Status: unknown.
02
Drugs
nab-paclitaxel
03
Conditions
hepatocellular carcinoma (HCC)intrahepatic cholangiocarcinoma (ICC)extrahepatic cholangiocarcinoma (eCCA)gallbladder carcinomapancreatic cancer (PC)
Beyond the preview
Go deeper on NCT04060472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04060472.